The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbil

Trial Profile

The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbil

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Mar 2010

At a glance

  • Drugs Gabapentin enacarbil (Primary)
  • Indications Diabetic neuropathies; Migraine; Postherpetic neuralgia; Restless legs syndrome
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors XenoPort
  • Most Recent Events

    • 25 Mar 2010 New trial record
    • 01 Feb 2010 Results published in the International Journal of Clinical Pharmacology and Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top